Extracellular vesicles, responsible for cell-to-cell communication, might be a driver of fibrosis in systemic sclerosis, according to a recent paper in Arthritis and Rheumatology.
Ascendis’ hypoparathyroidism drug saddled with three-month delay at FDA
Ascendis Pharma will likely wait three more months to get an answer from the FDA on the review of its hypoparathyroidism drug. On Tuesday, Ascendis
May 15, 2024